Alan raises €480 million Series G led by Prosus, boosting European health‑tech funding
Executive summary: Alan secured a €480 million Series G funding round led by Prosus. The deal signals strong investor confidence in European health‑tech and adds to record venture funding in the sector.
Who is involved: Alan (health‑tech unicorn), Prosus (lead investor), and existing backers (not named).
Likely next: Proceeds will fund product development, geographic expansion, and potential follow‑on M&A or IPO activity.
Alan, a European health‑tech unicorn, closed a Series G round totaling €480 million, with Prosus acting as lead investor. The round values the company at a multi‑billion‑euro level, though the exact valuation was not disclosed. The investment reflects continued appetite for digital health ventures despite broader market volatility. Prosus’s involvement may bring strategic synergies with its existing consumer‑internet portfolio.
What's next — scenarios
Strategic Ecosystem Integration (50%)
Increased market share in Europe via Prosus's existing digital platform synergies.
- Announcement of integrated services within Prosus portfolio apps
- Expansion into new European regulatory markets
Scale-Driven Burn (30%)
High capital expenditure on user acquisition potentially delaying profitability.
- Reported increase in marketing spend
- Quarterly loss widening despite revenue growth
Valuation Compression/Downround Risk (20%)
Downstream investors may demand stricter terms in Series H.
- Broader fintech market downturn
- Regulatory changes affecting digital health margins
What to watch
- Alan's product expansion announcement (next 60 days)
- Prosus quarterly earnings report mentions (next 90 days)
- New EU healthcare digital policy updates (next 30 days)
Timeline
- — Health unicorn Alan raises €480m Series G round led by Prosus (Sifted)
Analysis — what this means
Likely next events
- The round may set a new benchmark for European health‑tech valuations
Sectors affected
- Health‑tech
- Digital health
- Venture capital
Regulatory implications
- Increased focus on data‑privacy compliance as Alan scales
Historical parallels
- Babylon Health’s Series F round in 2021
- Kry’s €500 million raise in 2022
- Oscar Health’s $1 billion round in 2020